Exhibit 107
Calculation Of Filing Fee Tables
Form S-8
(Form Type)
Organogenesis Holdings Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||
| Equity | Class A Common Stock, $0.0001 par value per share | Rule 457(c) and Rule 457(h) | 7,826,970(2) | $2.61(3) | $20,428,391.70 | $0.00011020 | $2,251.21 | |||||||
| Total Offering Amounts | $20,428,391.70 | $2,251.21 | ||||||||||||
| Total Fee Offsets | — | |||||||||||||
| Net Fee Due | $2,251.21 | |||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (the “Registration Statement”) shall also cover any additional shares of the Registrant’s Class A common stock, $0.0001 par value per share (the “Common Stock”) that becomes issuable under the Registrant’s 2018 Equity Incentive Plan (as amended through June 23, 2022) (the “Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock. |
| (2) | This Registration Statement covers 7,826,970 shares of the Registrant’s Common Stock, which are issuable pursuant to the Plan. |
| (3) | Estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $2.61, the average of the high and low prices of the Registrant’s Common Stock as reported on The Nasdaq Capital Market on December 6, 2022, which date is within five business days prior to the filing of this Registration Statement. |
